Volume 60, Issue 1, Pages (July 2011)

Slides:



Advertisements
Similar presentations
Volume 46, Issue 6, Pages (December 2004)
Advertisements

Volume 55, Issue 1, Pages 1-8 (January 2009)
The PSA Era is not Over for Prostate Cancer
Volume 68, Issue 3, Pages (September 2015)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
Volume 51, Issue 2, Pages (February 2007)
Volume 62, Issue 5, Pages (November 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
European Urology Focus
Volume 70, Issue 1, Pages (July 2016)
Volume 62, Issue 5, Pages (November 2012)
Volume 61, Issue 6, Pages (June 2012)
Volume 57, Issue 3, Pages e22-e23 (March 2010)
Volume 54, Issue 6, Pages (December 2008)
The Correlation Between Metabolic Syndrome and Prostatic Diseases
Volume 57, Issue 6, Pages (June 2010)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Let the Games Begin (with EAU Approval)
Volume 73, Issue 5, Pages (May 2018)
Volume 64, Issue 3, Pages (September 2013)
Prostate Cancer Epidemic in Sight?
Volume 58, Issue 1, Pages (July 2010)
Re: Marcus G. Cumberbatch, Matteo Rota, James W. F
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 189, Issue 1, Pages (January 2013)
Volume 51, Issue 1, Pages (January 2007)
Volume 66, Issue 4, Pages (October 2014)
Prostate Cancer Detection: A View of the Future
Volume 54, Issue 5, Pages (November 2008)
Next-generation Sequencing of Urologic Cancers: Next Is Now
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 50, Issue 4, Pages (October 2006)
Volume 60, Issue 1, Pages (July 2011)
Volume 70, Issue 1, Pages (July 2016)
Is Benign Prostatic Hyperplasia (BPH) an Immune Inflammatory Disease?
Volume 56, Issue 2, Pages (August 2009)
Inflammation and Chronic Prostatic Diseases: Evidence for a Link?
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Volume 54, Issue 2, Pages (August 2008)
Prostate Cancer Epidemic in Sight?
The PSA Era is not Over for Prostate Cancer
Volume 71, Issue 4, Pages (April 2017)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
11C-Choline Positron Emission Tomography for the Evaluation after Treatment of Localized Prostate Cancer  I.J de Jong, J Pruim, P.H Elsinga, W Vaalburg,
Volume 61, Issue 6, Pages (June 2012)
Volume 56, Issue 1, Pages (July 2009)
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.
Tillmann Loch, Pat Fox Fulgham  European Urology 
Volume 68, Issue 6, Pages e134-e135 (December 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant Potential  Liang Cheng, Rodolfo Montironi,
Volume 62, Issue 3, Pages (September 2012)
Volume 64, Issue 4, Pages (October 2013)
Volume 50, Issue 5, Pages (November 2006)
Volume 55, Issue 6, Pages (June 2009)
Volume 53, Issue 6, Pages (June 2008)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Prostate Cancer Nomograms: An Update
Volume 69, Issue 5, Pages (May 2016)
European Urology is “Your” Journal
Volume 54, Issue 1, Pages (July 2008)
Complex Mechanisms in Prostatic Inflammatory Response
Volume 53, Issue 2, Pages (February 2008)
Volume 51, Issue 2, Pages (February 2007)
Volume 54, Issue 3, Pages (September 2008)
Volume 52, Issue 5, Pages (November 2007)
Volume 51, Issue 5, Pages (May 2007)
Michael Marberger  European Urology Supplements 
Presentation transcript:

Volume 60, Issue 1, Pages 106-117 (July 2011) The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation  Cosimo De Nunzio, Gero Kramer, Michael Marberger, Rodolfo Montironi, William Nelson, Fritz Schröder, Alessandro Sciarra, Andrea Tubaro  European Urology  Volume 60, Issue 1, Pages 106-117 (July 2011) DOI: 10.1016/j.eururo.2011.03.055 Copyright © 2011 European Association of Urology Terms and Conditions

Fig. 1 The distribution of inflammation, benign prostatic hyperplasia, proliferative inflammatory atrophy (PIA), high-grade intraepithelial neoplasia (HGPIN), and prostate cancer (PCa) in the human prostate: (A) a single slice of a prostate from a radical prostatectomy specimen, (B) a microscopic image (haematoxylin and eosin). (C) In a low-magnification microscopic image of the region indicated in (B) and a higher-magnification image of the different lesions observed, inflammation is shown by the red line and arrow, PIA by the white line and arrow, HGPIN by the green line and arrow, and PCa by the black line and arrow). BPH=benign prostatic hyperplasia; PCa=prostate cancer; HGPIN=high-grade intraepithelial neoplasia; PIA=proliferative inflammatory atrophy. European Urology 2011 60, 106-117DOI: (10.1016/j.eururo.2011.03.055) Copyright © 2011 European Association of Urology Terms and Conditions